166 related articles for article (PubMed ID: 37840448)
1. Associations of non-alcoholic fatty liver disease and cirrhosis with liver cancer in European and East Asian populations: A Mendelian randomization study.
Deng Y; Huang J; Wong MCS
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1913. PubMed ID: 37840448
[TBL] [Abstract][Full Text] [Related]
2. Causal impacts of educational attainment on chronic liver diseases and the mediating pathways: Mendelian randomization study.
Wang Y; Kong L; Ye C; Dou C; Zheng J; Xu M; Xu Y; Li M; Zhao Z; Lu J; Chen Y; Wang W; Ning G; Bi Y; Wang T
Liver Int; 2023 Nov; 43(11):2379-2392. PubMed ID: 37409353
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.
Au Yeung SL; Borges MC; Wong THT; Lawlor DA; Schooling CM
Int J Epidemiol; 2023 Jun; 52(3):921-931. PubMed ID: 36367831
[TBL] [Abstract][Full Text] [Related]
4. A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.
Li X; Xie Y; Tang L; Li D; Wang J; Sheng H; Chen K; Xiao S; Li J; Yang M
Front Endocrinol (Lausanne); 2023; 14():1343367. PubMed ID: 38269249
[TBL] [Abstract][Full Text] [Related]
5. Association between green tea intake and digestive system cancer risk in European and East Asian populations: a Mendelian randomization study.
Nie D; He X; Zheng H; Deng D; He F; Li R; Ni X; Li S; Xu F
Eur J Nutr; 2024 Jun; 63(4):1103-1111. PubMed ID: 38319384
[TBL] [Abstract][Full Text] [Related]
6. Association between circulating biomarkers and non-alcoholic fatty liver disease: An integrative Mendelian randomization study of European ancestry.
Chen D; Zhang Y; Zhou Y; Liu Y
Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):404-417. PubMed ID: 37973425
[TBL] [Abstract][Full Text] [Related]
7. Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
Zhang Z; Li M; Ji G; Zhang L
Eur J Clin Invest; 2024 Mar; 54(3):e14116. PubMed ID: 37916519
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
9. Association between air pollution and primary liver cancer in European and east Asian populations: a Mendelian randomization study.
Sun M; Gao M; Luo M; Wang T; Zhong T; Qin J
Front Public Health; 2023; 11():1212301. PubMed ID: 37575092
[TBL] [Abstract][Full Text] [Related]
10. Association between serum uric acid and prostate cancer risk in East Asian populations: a Mendelian randomization study.
Deng Y; Huang J; Wong MCS
Eur J Nutr; 2023 Apr; 62(3):1323-1329. PubMed ID: 36542132
[TBL] [Abstract][Full Text] [Related]
11. Plasma phospholipid arachidonic acid in relation to non-alcoholic fatty liver disease: Mendelian randomization study.
Chen J; Ruan X; Sun Y; Li X; Yuan S; Larsson SC
Nutrition; 2023 Feb; 106():111910. PubMed ID: 36459845
[TBL] [Abstract][Full Text] [Related]
12. Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease.
Yuan S; Larsson SC
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):398-405.e4. PubMed ID: 35101633
[TBL] [Abstract][Full Text] [Related]
13. Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study.
Zhang Z; Burrows K; Fuller H; Speliotes EK; Abeysekera KWM; Thorne JL; Lewis SJ; Zulyniak MA; Moore JB
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986172
[TBL] [Abstract][Full Text] [Related]
14. Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study.
Tao M; Zhou G; Liu J; He M; Wang C; Luo X; Zhang L
Clin Endocrinol (Oxf); 2023 Oct; 99(4):370-377. PubMed ID: 37559547
[TBL] [Abstract][Full Text] [Related]
15. The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.
Huang Q; Guo J; Zhao H; Zheng Y; Zhang Y
PLoS One; 2023; 18(10):e0292881. PubMed ID: 37856513
[TBL] [Abstract][Full Text] [Related]
16. Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study.
Tremblay M; Perrot N; Ghodsian N; Gobeil É; Couture C; Mitchell PL; Thériault S; Arsenault BJ
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3178-e3184. PubMed ID: 33693708
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations.
Yuan S; Chen J; Ruan X; Vithayathil M; Kar S; Li X; Mason AM; Burgess S; Larsson SC
Arthritis Res Ther; 2022 Dec; 24(1):270. PubMed ID: 36514134
[TBL] [Abstract][Full Text] [Related]
18. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Li S; Fu Y; Liu Y; Zhang X; Li H; Tian L; Zhuo L; Liu M; Cui J
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3497-e3503. PubMed ID: 35363278
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.
Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC
Am J Clin Nutr; 2022 Dec; 116(6):1595-1609. PubMed ID: 36205540
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.
Zhou BG; Xia JL; Jiang X; Ding YB; She Q
BMC Endocr Disord; 2024 Mar; 24(1):40. PubMed ID: 38504196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
